An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.
Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.
Diskapi Training and Research Hospital, Ankara, Turkey
South Valley University, Qinā, Egypt
Hospital das Clínicas - Faculdade de Medicina da Universidade de Sao Paulo, São Paulo, Brazil
Department of Anesthesiology, The Eye, Ear, Nose and Throat Hospital of Fudan University, Shanghai, Shanghai, China
AHEPA University Hospital, Thessaloniki, Greece
National Center for Child Health and Development, Setagaya-ku, Tokyo, Japan
Children's Healthcare of Atlanta-Egleston, Atlanta, Georgia, United States
University Hospitals Rainbow Babies and Children's Hospital, Cleveland, Ohio, United States
Faculty of Medicine,Zagazig University, Zagazig, Zagazig, Elsharkia,egypt, Egypt
Rabin Medical Center, Petach Tikva, Israel
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.